West Pharmaceutical Services Inc. (WST): Price and Financial Metrics
GET POWR RATINGS... FREE!
WST Price/Volume Stats
Current price | $343.50 | 52-week high | $376.72 |
Prev. close | $340.20 | 52-week low | $206.19 |
Day low | $340.03 | Volume | 340,900 |
Day high | $346.14 | Avg. volume | 522,402 |
50-day MA | $352.54 | Dividend yield | 0.22% |
200-day MA | $287.66 | Market Cap | 25.50B |
WST Stock Price Chart Interactive Chart >
WST POWR Grades
- WST scores best on the Sentiment dimension, with a Sentiment rank ahead of 87.03% of US stocks.
- WST's strongest trending metric is Growth; it's been moving down over the last 179 days.
- WST ranks lowest in Momentum; there it ranks in the 6th percentile.
WST Stock Summary
- With a market capitalization of $25,290,736,240, WEST PHARMACEUTICAL SERVICES INC has a greater market value than 91.62% of US stocks.
- WEST PHARMACEUTICAL SERVICES INC's stock had its IPO on January 5, 1988, making it an older stock than 90.53% of US equities in our set.
- The price/operating cash flow metric for WEST PHARMACEUTICAL SERVICES INC is higher than 88.35% of stocks in our set with a positive cash flow.
- If you're looking for stocks that are quantitatively similar to WEST PHARMACEUTICAL SERVICES INC, a group of peers worth examining would be ALGN, FTV, CSGP, XYL, and GGG.
- WST's SEC filings can be seen here. And to visit WEST PHARMACEUTICAL SERVICES INC's official web site, go to www.westpharma.com.
WST Valuation Summary
- In comparison to the median Healthcare stock, WST's price/sales ratio is 300% higher, now standing at 8.8.
- Over the past 243 months, WST's EV/EBIT ratio has gone up 17.9.
Below are key valuation metrics over time for WST.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
WST | 2023-05-23 | 8.8 | 9.2 | 46.1 | 36.7 |
WST | 2023-05-22 | 9.0 | 9.4 | 47.2 | 37.6 |
WST | 2023-05-19 | 9.0 | 9.4 | 47.3 | 37.7 |
WST | 2023-05-18 | 9.0 | 9.4 | 47.2 | 37.6 |
WST | 2023-05-17 | 9.0 | 9.3 | 46.8 | 37.3 |
WST | 2023-05-16 | 9.1 | 9.5 | 47.7 | 38.0 |
WST Growth Metrics
- The 5 year net income to common stockholders growth rate now stands at 42.95%.
- The 5 year cash and equivalents growth rate now stands at 97.93%.
- Its 5 year net cashflow from operations growth rate is now at 58.88%.

The table below shows WST's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-12-31 | 2,886.9 | 724 | 585.9 |
2022-09-30 | 2,909 | 654 | 630.6 |
2022-06-30 | 2,928.6 | 675.2 | 685.6 |
2022-03-31 | 2,880.9 | 646.5 | 684.4 |
2021-12-31 | 2,831.6 | 584 | 661.8 |
2021-09-30 | 2,681 | 571.9 | 612.5 |
WST's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- WST has a Quality Grade of B, ranking ahead of 77.04% of graded US stocks.
- WST's asset turnover comes in at 0.924 -- ranking 9th of 22 Rubber and Plastic Products stocks.
- TUP, MYE, and ENTG are the stocks whose asset turnover ratios are most correlated with WST.
The table below shows WST's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-09-30 | 0.924 | 0.405 | 0.359 |
2021-06-30 | 0.913 | 0.394 | 0.328 |
2021-03-31 | 0.885 | 0.375 | 0.281 |
2020-12-31 | 0.857 | 0.358 | 0.238 |
2020-09-30 | 0.852 | 0.348 | 0.220 |
2020-06-30 | 0.850 | 0.341 | 0.206 |
WST Price Target
For more insight on analysts targets of WST, see our WST price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $436.00 | Average Broker Recommendation | 1.5 (Moderate Buy) |
West Pharmaceutical Services Inc. (WST) Company Bio
West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. Founded in 1923 by Herman O. West and J.R. Wike of Philadelphia, the company is headquartered in Exton, Pennsylvania. In its early years of development, West produced rubber components for packaging injectable drugs, providing a sterile environment for the producers of penicillin and insulin. (Source:Wikipedia)
Latest WST News From Around the Web
Below are the latest news stories about WEST PHARMACEUTICAL SERVICES INC that investors may wish to consider to help them evaluate WST as an investment opportunity.
Here's Why You Should Retain Glaukos (GKOS) in Your PortfolioGlaukos (GKOS) continues to benefit from a robust product portfolio and favorable clinical trial results. |
Is West Pharmaceutical Services, Inc.'s (NYSE:WST) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?West Pharmaceutical Services' (NYSE:WST) stock is up by a considerable 35% over the past three months. Since the market... |
West to Participate in Upcoming Investor ConferenceWest Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the Bank of America Securities 2023 Health Care Conference in Las Vegas, NV, on Thursday, May 11, 2023, at 8:00 am PDT. |
3 Overvalued S&P 500 Stocks to Dump NowInvestors should consider taking profits on these overvalued S&P 500 stocks now with a potential recession on the horizon. |
West's Ready Pack™ containment solution with Corning® Valor® RTU Vials utilizing Stevanato Group's EZ-fill® technology recognized for Best Technologies Award at INTERPHEXWest Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, is pleased to announce that its West Ready Pack™ containment solution with Corning® Valor® RTU Vials utilizing Stevanato Group's EZ-fill® technology recently won the Best Technologies Award at INTERPHEX. The Best Technologies Award recognizes cutting-edge technologies, either new technologies or a novel implementation of existing technologies, that have the potential to cha |
WST Price Returns
1-mo | -4.91% |
3-mo | 8.40% |
6-mo | 46.56% |
1-year | 7.23% |
3-year | 60.09% |
5-year | 271.06% |
YTD | 46.13% |
2022 | -49.70% |
2021 | 65.88% |
2020 | 89.05% |
2019 | 54.13% |
2018 | -0.08% |
WST Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
Continue Researching WST
Want to do more research on West Pharmaceutical Services Inc's stock and its price? Try the links below:West Pharmaceutical Services Inc (WST) Stock Price | Nasdaq
West Pharmaceutical Services Inc (WST) Stock Quote, History and News - Yahoo Finance
West Pharmaceutical Services Inc (WST) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...